November 15, 2016 / 5:01 PM / 2 years ago

BUZZ-U.S. STOCKS ON THE MOVE-Teva, Cellectar, Equity One,

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, here ; for the Morning News Call newsletter, here ) The S&P 500 and the Nasdaq rose on Tuesday as tech stocks were back in demand after a post-election drubbing, while the Dow took a breather following a six-day rally.

The Dow Jones Industrial Average was down 0.26 percent at 18,818.94, the S&P 500 was up 0.30 percent at 2,170.79 and the Nasdaq Composite was up 0.84 percent at 5,262.026.

** APPLE INC,$106.905, +1.13 pct

Apple is considering expanding into wearable glass headsets and has talked about the project with potential suppliers, Bloomberg reported citing people familiar with the matter.

** REGENCY CENTERS CORP, $68.17, -2.42 pct

** EQUITY ONE INC, $30.34, +8.86 pct

Grocery shopping center owner Regency Centers said it would buy Equity One for about $4.6 billion, adding shopping centers in urban areas like New York and Los Angeles to its portfolio.

** HOME DEPOT INC, $124.31, -2.63 pct

The No. 1 U.S. home improvement chain did not lift its full-year sales forecast, implying a weaker-than-expected fourth quarter amid an improving housing market and higher consumer spending in the United States.

** JD.COM INC, $26.7901, +12.99 pct

China’s second-largest e-commerce firm said its third-quarter revenue grew 38 percent from a year ago, slightly ahead of analysts’ expectations.

** STRATASYS LTD, $17.2751, -15.73 pct

** 3D SYSTEMS CORP, $13.81, -3.43 pct

3D printer maker Stratasys’s third-quarter revenue and profit missed market expectations. The company also lowered its FY16 guidance below Wall Street estimates.

Rival 3D Systems was also down.

** FINISH LINE INC, $22.24, -3.09 pct

The sportswear retailer said it would explore strategic alternatives, including a sale, for specialty running store chain JackRabbit.

** VIKING THERAPEUTICS INC, $1.2, +3.45 pct

The drug developer reported additional data from its completed early-stage clinical trial of VK2809, in patients with mild hypercholesterolemia.

** TESARO INC, $131.71, -11.31 pct

The stock retreated from Monday’s record high close after the cancer drug developer priced its follow-on offering of 1.75 million shares at $135.00, a 9.1 pct discount to the stock’s last sale of $148.50. The deal represents 3.3 percent of the company’s outstanding shares.


The heavily indebted Canadian drugmaker, trying to sell non-core assets, has received offers for some core businesses, Chief Executive Joe Papa said on Tuesday.

** AMERICAN AIRLINES INC, $44.5641, +2.68 pct

** DELTA AIR LINES INC, $47.54, +0.15 pct

** SOUTHWEST AIRLINES CO, $45.99, +1.41 pct


Warren Buffett’s Berkshire Hathaway said it has bought shares in the four biggest U.S. airlines: American Airlines, Delta Air Lines, Southwest Airlines and United Continental.


The world’s biggest generic drugmaker cut its 2016 earnings-per-share forecast to $5.10-$5.20 from $5.20-$5.40. The company also reduced its revenue guidance to $21.6 billion-$21.9 billion, from $22 billion-$22.5 billion.

** CELLECTAR BIOSCIENCES INC, $2.3501, +26.35 pct

** RESEARCH HOLDINGS INC, $50, -1.48 pct

Cellectar is teaming up with contract research organization Research Holdings to oversee a mid-stage study of its experimental drug, CLR 131, in patients with multiple myeloma and certain hematologic malignancies.

** WELLS FARGO & CO, $51.71, -2.84 pct

** JPMORGAN CHASE, $78.13, -1.74 pct

** BANK OF AMERICA, $19.785, -1.47 pct

The banks’ stocks fell as investors took some profits after a dramatic post-election rally of the sector. (Compiled by Laharee Chatterjee in Bengaluru; Editing by Maju Samuel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below